Skip to content

Orthotics in Ambulatory Cerebral Palsy

Relationship of Orthotics to Activity and Participation in Children With Cerebral Palsy

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01527162
Acronym
SAFO
Enrollment
11
Registered
2012-02-06
Start date
2012-01-31
Completion date
2014-07-31
Last updated
2021-06-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebral Palsy

Keywords

Cerebral palsy, orthotics, solid ankle foot orthoses

Brief summary

This project will examine the effect of solid ankle foot orthoses (SAFO) on day to day walking activity and life participation of ambulatory children with cerebral palsy. The investigators propose that SAFO have not effect on levels of walking and life participation versus not wearing the SAFO.

Detailed description

This is a repeated measures trial with randomization of intervention in a cross over design which will quantify daily walking and physical activity levels for children with cerebral palsy (CP) with and without use of a solid ankle foot orthotic (SAFO). Current orthotic management guidelines are based primarily on evidence that SAFO use positively impacts body function and structure in clinic and lab based observations of activity and movement. Prior research has determined that wearing a SAFO improves different aspects of gait and mobility (stride and step length, single limb stance, velocity) for children with CP. However, these studies have been limited by small sample sizes, lack of comparison groups, inconsistency of orthotic fabrication, lack of clear and simple outcome measures and/or randomized control designs. No prior studies have evaluated the effect of SAFO use on activity performance outcomes. The purpose of this study is to determine the effect of wearing or not wearing current SAFO on a child's walking ability, participation in common life activities, and gait. Children ages 2 - \< 10 years who have bilateral cerebral palsy, dynamic equinus gait deformity, and wear bilateral SAFOs fabricated by Cascade DAFO will be approached for participation. Enrolled children are randomly assigned to either wear or not wear their SAFOs for a 14 day intervention period. After this period is over, children will then do the opposite for a second 14 day intervention period. Children attend three study visits; at enrollment, after the first intervention period is over, and after the second intervention period. At the first visit, parents and children (where applicable) complete questionnaires regarding their participation in common life activities in the prior 7 days, and complete a walking evaluation. Children wear a StepWatch accelerometer during each intervention period, which counts the number of steps the child takes and the time each step was taken. After the second intervention period is complete, the child's participation in the research study is complete. One home visit is conducted at the end of each intervention period, where the questionnaires are repeated, and the StepWatch is downloaded and/or re - calibrated per protocol.

Interventions

OTHERSAFO not worn

Child does not wear their prescirbed SAFO for 14 days by random assignment

DEVICESAFO worn

Child wears their prescribed SAFO for 14 days by random assignment

Sponsors

Seattle Children's Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
2 Years to 9 Years
Healthy volunteers
No

Inclusion criteria

1. Age 2 to \<10 years 2. Gross Motor Function Classification Scale Score of 1 - 3 (ambulatory) 3. Diagnosed with bilateral cerebral palsy 4. Has dynamic equinus gait deformity, defined as PROM to neutral, with equinus weight bearing pattern. 5. Wears bilateral SAFO more than 8 hours per day for more than one month. 6. Has a SAFO prescription of ankle at neutral (zero plantarflexion, with \<10 degrees dorsiflexion). 7. The primary goal of the SAFO is to facilitate balance and walking 8. Has SAFOs fabricated by Cascade DAFO, Ferndale, WA. 9. Parent and child are willing to discontinue SAFO use for two weeks.

Exclusion criteria

1. Has visual impairment which limits physical activity. 2. Has had lower extremity Botox injections in the past 3 months. 3. Is expected to require changes to medications treating the movement disorder during the study period. 4. Has an uncontrolled seizure disorder which impacts mobility skills. 5. Has had neurosurgical or orthopedic surgeries in the past 6 months. 6. Has had other surgeries or procedures in the past two weeks.

Design outcomes

Primary

MeasureTime frameDescription
Walking Activity Levelsaverage of 5 days of second week of interventionDaily walking activity will be measured with the StepWatch accelerometer documenting average strides/day.

Secondary

MeasureTime frameDescription
Physical Activity Scale for Kids - Performance Version (ASKp)previous 7 day referencePhysical activity will be by parental report of Physical Activities Scale for Kids performance version (ASKp) survey- total score. Scale ranges from 0 to 100 with higher scores representing more physical activity. A score of 100 on this criterion referenced evalutive measure is consistent with physical activity like that of a typically developing 5 year old.
Assessment of Life Habits for Children (LIFE-H)previous 7 day referenceParticipation in habits of daily life will be by parental report of the Life Habits questionnaire(Life-H for children) by the weighted total score on a scale of 0 to 9, with a higher score representing more participation in habits of daily life.

Countries

United States

Participant flow

Participants by arm

ArmCount
All Participants
We used a randomized cross-over design with eleven children with bilateral 9 CP, mean age 4.3 years. Subjects were randomized to their current SAFO worn or SAFO not worn for 2 weeks and then crossed over.
11
Total11

Baseline characteristics

CharacteristicAll Participants
Age, Categorical
<=18 years
11 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
0 Participants
Age, Continuous4.3 years
Region of Enrollment
United States
11 participants
Sex: Female, Male
Female
4 Participants
Sex: Female, Male
Male
7 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 110 / 11
serious
Total, serious adverse events
0 / 110 / 11

Outcome results

Primary

Walking Activity Levels

Daily walking activity will be measured with the StepWatch accelerometer documenting average strides/day.

Time frame: average of 5 days of second week of intervention

ArmMeasureValue (MEAN)Dispersion
SAFO WornWalking Activity Levels4660 average total strides/dayStandard Deviation 1421
SAFO Not WornWalking Activity Levels4897 average total strides/dayStandard Deviation 1438
p-value: <0.05Wilcoxon (Mann-Whitney)
Secondary

Assessment of Life Habits for Children (LIFE-H)

Participation in habits of daily life will be by parental report of the Life Habits questionnaire(Life-H for children) by the weighted total score on a scale of 0 to 9, with a higher score representing more participation in habits of daily life.

Time frame: previous 7 day reference

ArmMeasureValue (MEAN)Dispersion
SAFO WornAssessment of Life Habits for Children (LIFE-H)5.71 units on a scaleStandard Deviation 2
SAFO Not WornAssessment of Life Habits for Children (LIFE-H)5.11 units on a scaleStandard Deviation 2.2
Comparison: Paired Wilcoxon Sign Rank TEstp-value: >0.54Wilcoxon (Mann-Whitney)
p-value: =0.2Wilcoxon (Mann-Whitney)
Secondary

Physical Activity Scale for Kids - Performance Version (ASKp)

Physical activity will be by parental report of Physical Activities Scale for Kids performance version (ASKp) survey- total score. Scale ranges from 0 to 100 with higher scores representing more physical activity. A score of 100 on this criterion referenced evalutive measure is consistent with physical activity like that of a typically developing 5 year old.

Time frame: previous 7 day reference

ArmMeasureValue (MEAN)Dispersion
SAFO WornPhysical Activity Scale for Kids - Performance Version (ASKp)51.08 units on a scaleStandard Deviation 11.64
SAFO Not WornPhysical Activity Scale for Kids - Performance Version (ASKp)49.45 units on a scaleStandard Deviation 14.2
p-value: =0.14Wilcoxon (Mann-Whitney)

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026